Business Context and Reporting Period
Company: Icecure Medical Ltd.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: March 2024 (Report No. 2)
Date of Filing: March 12, 2024
This filing reports a corporate event regarding intellectual property rather than financial results. The Company issued a press release announcing the receipt of a Notice of Patent Allowance in Japan for a novel cryogen flow control technology designed to optimize patient outcomes.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This Form 6-K is a current report of a specific event and does not contain financial statements or performance metrics.
Material Changes
Intellectual Property: The Company received a Notice of Patent Allowance in Japan for a novel cryogen flow control system. This represents a material development in the Company's intellectual property portfolio and potential market expansion in Japan.
Guidance, Outlook, and Risks
Management Commentary: The filing incorporates by reference the first two paragraphs and the "Forward Looking Statements" section of the March 12, 2024 press release. The press release highlights the strategic importance of the patent allowance for optimizing patient outcomes.
Risks and Contingencies: The filing references standard forward-looking statements regarding future events, but does not detail specific new risks or contingencies beyond those typically associated with patent prosecution and commercialization.
Investor Verification Checklist
- Verify the scope and enforceability of the newly allowed patent in Japan.
- Review the full text of the March 12, 2024 press release (Exhibit 99.1) for details on the "Forward Looking Statements."
- Confirm the timeline for commercialization of the cryogen flow control technology in the Japanese market.
- Check subsequent filings for any updates on the patent issuance or related regulatory approvals.